Evidence map›Paper›PMID 40950597›Full record

ArticleFrontiers in microbiology2025

Real-time evaluation of antibacterial efficacy using bioluminescent assays for

Manali Patil, Congyu Luo, Ganna Petruk, Jitka Petrlova, Artur Schmidtchen, Manoj Puthia

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Manali PatilDivision of Dermatology and Venereology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Congyu LuoDivision of Dermatology and Venereology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Ganna PetrukDivision of Dermatology and Venereology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Jitka PetrlovaDivision of Dermatology and Venereology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Artur SchmidtchenDivision of Dermatology and Venereology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Manoj PuthiaDivision of Dermatology and Venereology, Department of Clinical Sciences, Lund University, Lund, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of antibiotic resistance necessitates effective strategies for evaluating antimicrobial agents. Bioluminescent bacteria, either naturally occurring or engineered with modified reporter genes like bacterial luciferase, provide real-time assessment of bacterial viability through light emission. We investigated the antibacterial effects of cefotaxime and doxycycline using bioluminescent strains of

Indexed as

antibiotic resistanceantimicrobial susceptibility testingbioluminescent assayluciferasePseudomonas aeruginosareal-time monitoringStaphylococcus aureus

Identifiers

PMID40950597
PMCPMC12426007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.